Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis - insights from a longitudinal FMRI study.
Rehabilitation interventions for the management of multiple sclerosis relapse: a short scoping review.
Epstein-Barr virus in multiple sclerosis.
The role of transcriptional control in multiple system atrophy.
Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model.
Not Lost in Translation: Emerging Clinical Importance of the G Protein-Coupled Estrogen Receptor GPER.
Effect of Bushen Yisui Capsule () on oligodendrocyte lineage genes 1 and 2 in mice with experimental autoimmune encephalomyelitis.
Therapeutic effects of anti-Delta1 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.
Multiple sclerosis in men: management considerations.
Erythropoietin: new directions for the nervous system.
Smoking as a risk factor for multiple sclerosis.
The Usefulness of Gadolinium-Enhanced Images on a Follow-up Magnetic Resonance Image in Suspected Multiple Sclerosis.
MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentary.
Hypomorphic MGAT5 polymorphisms promote multiple sclerosis cooperatively with MGAT1 and interleukin-2 and 7 receptor variants.
What is the true clinicopathologic spectrum of neuromyelitis optica?-Reply.
[Cognitive disorders in multiple sclerosis: correlations between neuropsychological, neurophysiological and neuroimaging characteristics.]
Serum amyloid A level is increased in neuromyelitis optica and atypical multiple sclerosis with smaller T2 lesion volume in brain MRI.
Interferon-Beta Induces Distinct Gene Expression Response Patterns in Human Monocytes versus T cells.
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply.
Another promising oral agent for multiple sclerosis.
Natalizumab: Bench to Bedside and Beyond.
A Psychometric Validation of Two Brief Measures to Assess Palliative Need in Patients Severely Affected by Multiple Sclerosis.
Multiple sclerosis, an unlikely cause of chronic cerebrospinal venous insufficiency: retrospective analysis of catheter venography.
Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study.

Pages